Cytosorbents (CTSO) Other Non-Current Liabilities (2014 - 2017)

Cytosorbents' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $1.0 million for Q2 2017.

• Quarterly Other Non-Current Liabilities fell 42.13% year-over-year to $1.0 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.0 million (down 42.13% YoY) and the FY2016 annual result came in at $1.8 million, up 10.72% from the prior year.
• Other Non-Current Liabilities was $1.0 million for Q2 2017 at Cytosorbents, down from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.0 million in Q4 2014 and bottomed at $1.0 million in Q2 2017.
• A 4-year average of $1.9 million and a median of $1.7 million in 2016 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2015 — Other Non-Current Liabilities slumped 45.12% — and 2016, when it climbed 10.72%.
• Cytosorbents' Other Non-Current Liabilities stood at $3.0 million in 2014, then slumped by 45.12% to $1.6 million in 2015, then increased by 10.72% to $1.8 million in 2016, then slumped by 42.23% to $1.0 million in 2017.
• Business Quant data shows CTSO's Other Non-Current Liabilities at $1.0 million in Q2 2017, $1.7 million in Q1 2017, and $1.8 million in Q4 2016.